查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1379188

2023-2028 年按产品类型、筛检、疾病、最终用户和地区分類的产前和新生儿基因检测市场报告

Prenatal and Newborn Genetic Testing Market Report by Product Type, Screening, Disease, End User, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年，全球产前和新生儿基因检测市场规模达到53亿美元。展望未来， IMARC Group预计到2028年市场规模将达到112亿美元，2022-2028年复合年增长率（CAGR）为13.3%。对先进诊断和筛检设备的需求不断增长、世界各地新生儿先天畸形和遗传异常患病率不断上升以及医疗行业的蓬勃发展是推动市场的一些关键因素。

产前和新生儿基因检测包括血液检测、特定类型的超音波检测和产前游离 DNA 筛检，为未出生婴儿和新生儿的基因组成提供宝贵的见解。它可以识别某些出生缺陷，其中许多是未出生或新生儿的遗传性疾病。它为准父母、医疗保健专业人员和研究人员提供重要信息，使他们能够就婴儿的健康和福祉做出明智的决定。它有助于改善患者的治疗结果并指导医疗干预，同时能够准确识别怀孕和婴儿早期的遗传变异和异常。它还有助于检测各种先天性疾病，如唐氏症、囊性纤维化、镰状细胞疾病和苯酮尿症。由于它有助于分析父母血液中的各种蛋白质水平，以确定婴儿染色体数量异常的风险，因此全球对产前和新生儿基因检测的需求正在增加。

产前和新生儿基因检测市场趋势：

目前，全球大众对先进诊断和筛检设备的需求不断增长，是支持市场成长的关键因素之一。此外，全世界新生儿先天畸形和基因异常的盛行率增加。这与蓬勃发展的医疗产业一起推动了市场的成长。此外，与传统方法相比，非侵入性产前筛检方法具有多种优点，例如准确度高、精确度高、痛苦少、诊断快速等，对市场的需求不断增长，正在对市场产生积极影响。除此之外，人们对产前和新生儿基因检测的好处的认识不断提高，为行业投资者提供了利润丰厚的成长机会。此外，由于注重健康的个人数量不断增加，对产前和新生儿基因检测的需求不断增加，也促进了市场的成长。除此之外，各国政府机构都致力于改善医疗基础设施，为国民提供更好的医疗服务。为此，主要参与者正在开发基因眼科测试，以确定患者罹患圆锥角膜和其他角膜营养不良的风险。此外，用于检测遗传性疾病风险的母体血浆检测对无细胞 DNA 的需求不断增长，这提供了有利的市场前景。

本报告回答的关键问题：

  • 迄今为止，全球产前和新生儿基因检测市场表现如何，未来几年将如何表现？
  • 全球产前和新生儿基因检测市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球产前和新生儿基因检测市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的产前和新生儿基因检测市场？
  • 依产品类型分類的市场是怎么样的？
  • 产前及新生儿基因检测市场最具吸引力的产品类型为何？
  • 根据筛选，市场的细分情况如何？
  • 产前及新生儿基因检测市场哪项筛检最具吸引力？
  • 基于疾病的市场崩盘是什么？
  • 产前及新生儿基因检测市场最具吸引力的疾病是？
  • 基于最终用户的市场区隔是什么？
  • 产前和新生儿基因检测市场中哪一个最有吸引力的最终用户？
  • 全球产前及新生儿基因检测市场竞争格局如何？
  • 全球产前和新生儿基因检测市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球产前与新生儿基因检测市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：依产品类型分類的市场区隔

  • 耗材
    • 市场走向
    • 市场预测
  • 仪器
    • 市场走向
    • 市场预测

第 7 章：透过筛选进行市场区隔

  • 非侵入性产前检测
    • 市场走向
    • 市场预测
  • 绒毛膜绒毛取样
    • 市场走向
    • 市场预测
  • 羊膜穿刺术
    • 市场走向
    • 市场预测
  • 母体血清筛检
    • 市场走向
    • 市场预测

第 8 章：疾病导致的市场区隔

  • 唐氏综合症
    • 市场走向
    • 市场预测
  • 苯酮尿症
    • 市场走向
    • 市场预测
  • 囊肿纤维化
    • 市场走向
    • 市场预测
  • 镰状细胞性贫血
    • 市场走向
    • 市场预测

第 9 章：最终用户的市场区隔

  • 医院
    • 市场走向
    • 市场预测
  • 妇产科和专科诊所
    • 市场走向
    • 市场预测
  • 诊断中心
    • 市场走向
    • 市场预测

第 10 章：按地区分類的市场细分

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 11 章：驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • BGI Group
    • Bio-Rad Laboratories Inc.
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • Laboratory Corporation of America Holdings
    • Natera Inc.
    • PerkinElmer Inc.
    • Quest Diagnostics Incorporated
    • Ravgen Inc.
Product Code: SR112023A11196

Abstract

The global prenatal and newborn genetic testing market size reached US$ 5.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.2 Billion by 2028, exhibiting a growth rate (CAGR) of 13.3% during 2022-2028. The growing demand for advanced diagnostic and screening devices, rising prevalence of congenital malformations and genetic abnormalities in newborn babies around the world, and thriving medical industry represent some of the key factors driving the market.

Prenatal and newborn genetic testing comprises blood tests, a specific type of ultrasound, and prenatal cell-free DNA screening that offers invaluable insights into the genetic makeup of unborn babies and newborns. It can identify certain birth defects, many of which are genetic disorders in unborn or newborn babies. It provides critical information to expectant parents, healthcare professionals, and researchers, enabling them to make informed decisions about the health and well-being of infants. It assists in improving patient outcomes and guiding medical interventions while enabling accurate identification of genetic variations and abnormalities during pregnancy and early infancy. It also aids in detecting various congenital conditions, such as Down syndrome, cystic fibrosis, sickle cell disease, and phenylketonuria. As it helps analyze various protein levels in the blood of parents to determine the risk for abnormal chromosome numbers in babies, the demand for prenatal and newborn genetic testing is rising across the globe.

Prenatal and Newborn Genetic Testing Market Trends:

At present, the rising demand for advanced diagnostic and screening devices among the masses across the globe represents one of the key factors supporting the growth of the market. In addition, there is an increase in the prevalence of congenital malformations and genetic abnormalities in newborn babies worldwide. This, along with the thriving medical industry, is propelling the growth of the market. Moreover, the growing demand for non-invasive prenatal screening methods due to their various benefits, such as high accuracy and precision, less pain, and fast diagnosis, as compared to conventional methods, is positively influencing the market. Besides this, the rising awareness among individuals about the benefits of prenatal and newborn genetic testing is offering lucrative growth opportunities to industry investors. Additionally, the escalating demand for prenatal and newborn genetic testing due to the increasing number of health-conscious individuals is contributing to the growth of the market. Apart from this, governing agencies of various countries are focusing on improving healthcare infrastructure to provide enhanced healthcare services to citizens. In line with this, key players are developing genetic eye tests to identify the risk of keratoconus and other corneal dystrophies in patients. Furthermore, the growing demand for cell-free DNA in maternal plasma tests to detect the risk of genetic disorders is offering a favorable market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global prenatal and newborn genetic testing market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product type, screening, disease, and end user.

Product Type Insights:

Consumables

Instruments

The report has provided a detailed breakup and analysis of the prenatal and newborn genetic testing market based on the product type. This includes consumables and instruments. According to the report, consumables represented the largest segment.

Screening Insights:

Non-invasive Prenatal Testing

Chorionic Villus Sampling

Amniocentesis

Maternal Serum Screening

A detailed breakup and analysis of the prenatal and newborn genetic testing market based on the screening has also been provided in the report. This includes non-invasive prenatal testing, chorionic villus sampling, amniocentesis, and maternal serum screening. According to the report, non-invasive prenatal testing accounted for the largest market share.

Disease Insights:

Downs Syndrome

Phenylketonuria

Cystic Fibrosis

Sickle Cell Anemia

A detailed breakup and analysis of the prenatal and newborn genetic testing market based on the disease has also been provided in the report. This includes downs syndrome, phenylketonuria, cystic fibrosis, and sickle cell anemia. According to the report, downs syndrome accounted for the largest market share.

End User Insights:

Hospital

Maternity and Specialty Clinics

Diagnostic Centers

A detailed breakup and analysis of the prenatal and newborn genetic testing market based on the end user has also been provided in the report. This includes hospital, maternity and specialty clinics, and diagnostic centers. According to the report, hospital accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for prenatal and newborn genetic testing. Some of the factors driving the North America prenatal and newborn genetic testing market included the growing number of pregnant women undergoing genetic screening, rising awareness about various inborn genetic diseases, enhanced healthcare infrastructure, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global prenatal and newborn genetic testing market. Detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, BGI Group, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., PerkinElmer Inc., Quest Diagnostics Incorporated, Ravgen Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global prenatal and newborn genetic testing market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global prenatal and newborn genetic testing market?
  • What is the impact of each driver, restraint, and opportunity on the global prenatal and newborn genetic testing market?
  • What are the key regional markets?
  • Which countries represent the most attractive prenatal and newborn genetic testing market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the prenatal and newborn genetic testing market?
  • What is the breakup of the market based on the screening?
  • Which is the most attractive screening in the prenatal and newborn genetic testing market?
  • What is the breakup of the market based on the disease?
  • Which is the most attractive disease in the prenatal and newborn genetic testing market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the prenatal and newborn genetic testing market?
  • What is the competitive structure of the global prenatal and newborn genetic testing market?
  • Who are the key players/companies in the global prenatal and newborn genetic testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Prenatal and Newborn Genetic Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Screening

  • 7.1 Non-invasive Prenatal Testing
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chorionic Villus Sampling
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Amniocentesis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Maternal Serum Screening
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Disease

  • 8.1 Downs Syndrome
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Phenylketonuria
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Cystic Fibrosis
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Sickle Cell Anemia
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospital
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Maternity and Specialty Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Diagnostic Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 BGI Group
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Bio-Rad Laboratories Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 F. Hoffmann-La Roche AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Illumina Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Laboratory Corporation of America Holdings
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Natera Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 PerkinElmer Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Quest Diagnostics Incorporated
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Ravgen Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Prenatal and Newborn Genetic Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Prenatal and Newborn Genetic Testing Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Product Type (in %), 2022
  • Figure 5: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Screening (in %), 2022
  • Figure 6: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Disease (in %), 2022
  • Figure 7: Global: Prenatal and Newborn Genetic Testing Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Prenatal and Newborn Genetic Testing (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Prenatal and Newborn Genetic Testing (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Prenatal and Newborn Genetic Testing (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Prenatal and Newborn Genetic Testing (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Prenatal and Newborn Genetic Testing (Non-invasive Prenatal Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Prenatal and Newborn Genetic Testing (Non-invasive Prenatal Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Prenatal and Newborn Genetic Testing (Chorionic Villus Sampling) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Prenatal and Newborn Genetic Testing (Chorionic Villus Sampling) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Prenatal and Newborn Genetic Testing (Amniocentesis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Prenatal and Newborn Genetic Testing (Amniocentesis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Prenatal and Newborn Genetic Testing (Maternal Serum Screening) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Prenatal and Newborn Genetic Testing (Maternal Serum Screening) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Prenatal and Newborn Genetic Testing (Downs Syndrome) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Prenatal and Newborn Genetic Testing (Downs Syndrome) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Prenatal and Newborn Genetic Testing (Phenylketonuria) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Prenatal and Newborn Genetic Testing (Phenylketonuria) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Prenatal and Newborn Genetic Testing (Cystic Fibrosis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Prenatal and Newborn Genetic Testing (Cystic Fibrosis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Prenatal and Newborn Genetic Testing (Sickle Cell Anemia) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Prenatal and Newborn Genetic Testing (Sickle Cell Anemia) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Prenatal and Newborn Genetic Testing (Hospital) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Prenatal and Newborn Genetic Testing (Hospital) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Prenatal and Newborn Genetic Testing (Maternity and Specialty Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Prenatal and Newborn Genetic Testing (Maternity and Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Prenatal and Newborn Genetic Testing (Diagnostic Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Prenatal and Newborn Genetic Testing (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: North America: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: North America: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: United States: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: United States: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Canada: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Canada: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Asia-Pacific: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Asia-Pacific: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: China: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: China: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Japan: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Japan: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: India: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: India: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: South Korea: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: South Korea: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Australia: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Australia: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Indonesia: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Indonesia: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Others: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Others: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Europe: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Europe: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Germany: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Germany: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: France: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: France: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: United Kingdom: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: United Kingdom: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Italy: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Italy: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Spain: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Spain: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Russia: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Russia: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Others: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Others: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Latin America: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Latin America: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Brazil: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Brazil: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Mexico: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Mexico: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Others: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Others: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Middle East and Africa: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Middle East and Africa: Prenatal and Newborn Genetic Testing Market: Breakup by Country (in %), 2022
  • Figure 83: Middle East and Africa: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Global: Prenatal and Newborn Genetic Testing Industry: Drivers, Restraints, and Opportunities
  • Figure 85: Global: Prenatal and Newborn Genetic Testing Industry: Value Chain Analysis
  • Figure 86: Global: Prenatal and Newborn Genetic Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Prenatal and Newborn Genetic Testing Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Screening (in Million US$), 2023-2028
  • Table 4: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Disease (in Million US$), 2023-2028
  • Table 5: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Prenatal and Newborn Genetic Testing Market: Competitive Structure
  • Table 8: Global: Prenatal and Newborn Genetic Testing Market: Key Players